RIPE-KG · Version 1.1.0 · Resource

ripekg:work/RIPEW509DA476F2D60603

https://w3id.org/ripe/ripe-kg/work/RIPEW509DA476F2D60603
SubjectPredicateObject
ripekg:work/10.1111%2Fadb.12650Expression of Concern: The effects of melatonin supplementation on mental health, metabolic and genetic profiles in patients under methadone maintenance treatment http://purl.org/spar/cito/cites ripekg:work/RIPEW509DA476F2D60603The cost-effectiveness and population outcomes of expanded HIV screening and antiretroviral treatment in the United States
ripekg:work/RIPEW509DA476F2D60603The cost-effectiveness and population outcomes of expanded HIV screening and antiretroviral treatment in the United States dcterms:title The cost-effectiveness and population outcomes of expanded HIV screening and antiretroviral treatment in the United States
ripekg:work/RIPEW509DA476F2D60603The cost-effectiveness and population outcomes of expanded HIV screening and antiretroviral treatment in the United States rdf:type node1
ripekg:work/RIPEW509DA476F2D60603The cost-effectiveness and population outcomes of expanded HIV screening and antiretroviral treatment in the United States rdf:type http://purl.org/spar/fabio/Work
ripekg:work/RIPEW509DA476F2D60603The cost-effectiveness and population outcomes of expanded HIV screening and antiretroviral treatment in the United States rdf:type rdfs:Resource
ripekg:work/RIPEW509DA476F2D60603The cost-effectiveness and population outcomes of expanded HIV screening and antiretroviral treatment in the United States rdf:type owl:Thing
ripekg:work/RIPEW509DA476F2D60603The cost-effectiveness and population outcomes of expanded HIV screening and antiretroviral treatment in the United States rdf:type prov:Entity
ripekg:work/RIPEW509DA476F2D60603The cost-effectiveness and population outcomes of expanded HIV screening and antiretroviral treatment in the United States rdf:type ripe:WorkWork